December 17, 2024 , 10:00 -11:00 AM PST

G4X Spatial Multiomic Data Showcase

High Resolution In-Situ Multiomic Analysis of FFPE Tissue at Scale on the G4X

Register below for a technical presentation focused on the groundbreaking features and multiomic capabilities of the G4X Spatial Sequencer. We will highlight performance results on immuno-oncology panels for kidney, lung, colon, and breast tissues.

Showcase Speakers

Kenneth Gouin, PhD.
Sr. Staff, Bioinformatics

Maria Elena Gallina, PhD.
Sr. Product Manager

Mayar Allam, PhD.
Field Application Scientist

Transcript, protein, and fH&E readout of tonsil cancer FFPE serial sections (10x10 mm). Data generated on a single flow cell.

Start Planning for G4X

Add your name to the list to receive important information about adopting G4X in your lab in 2025 and discuss next steps with our team. 

GET STARTED

Start Planning for G4X

Please provide your information and we will follow up with you about next steps.

Drew Spaventa

Drew founded Singular Genomics in 2016 serving as the CEO and Chairman. Drew is a serial entrepreneur and venture investor in the biotech industry and has been involved in the founding of several successful companies. Prior to Singular Genomics, Drew founded Truvian Sciences, a low volume blood testing technology aimed at making routine blood tests easier, less invasive, and more affordable. Drew was also involved in the founding of Aspen Neurosciences where he co-led the seed financing and helped assemble a world-class team to combat Parkinson’s Disease using a patient’s own stem cells. Drew was also a seed investor and held an operating role in Edico Genome which sold to Illumina in 2018.

Drew received an MBA from the Rady School of Management at the University of California, San Diego and a BA in Political Science and International Relations from the University of California, San Diego.

Drew Spaventa

Max Reads Application Note